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Abstract Purpose: Multiresistant
and vancomycin resistant Enterococ-
cus faecium (VRE) can cause serious
infections in hospitalized patients
with various co-morbid diseases. We
investigated the course of VRE peri-
tonitis after cecal ligation and
puncture (CLP)-induced sepsis and
compared this to sham operated mice.
Methods: Mice were subjected to
CLP or sham surgery. Forty-eight
hours thereafter four groups were
created by subjecting mice to perito-
neal injection of either VRE or saline.
Results: Mice infected with VRE
after CLP were severely impaired in
eliminating VRE from the peritoneal
cavity and distant body sites. These
mice failed to mount an early
inflammatory response at the primary
site of VRE infection. VRE superin-
fection did not influence CLP-
induced organ damage or polymicro-
bial bacterial loads.
Conclusions: Sublethal polymicro-
bial sepsis greatly facilitates infection
and dissemination of VRE. VRE does
not influence the course of CLP-
induced sepsis.
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Introduction
Infections with multiresistant and vancomycin resistant
Enterococcus faecium (VRE), are a growing problem
worldwide [1]. Severe infections with VRE are almost
exclusively found in immunocompromised patients,
including patients at intensive care units suffering from
different co-morbid conditions [2–4].
Patients who have survived the initial phase of sepsis
demonstrate features consistent with immune depression.
It has been proposed that this immune suppression
contributes to the enhanced susceptibility to nosocomial
infections and late mortality of sepsis patients [5–11].
Cecal ligation and puncture (CLP) is considered a clin-
ically relevant model to study the septic response [12].
Many studies that investigated the sepsis-induced state
of immunoparalysis used the model of CLP, especially
to examine host defense against secondary pneumonia
[13–15]. VRE is often cultured from abdominal infec-
tions, frequently resulting in subsequent dissemination to
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blood and distant organs [16, 17]. To investigate the
immune response to VRE infection we previously set up
a model of VRE peritonitis in mice [18]. Healthy mice
are able to mount an effective immune response in this
model with peak cytokine levels after 2–6 h and an early
peritoneal neutrophil influx, resulting in clearance of the
systemic infection in 2–3 days. We here aimed to obtain
insight into the innate immune response to VRE infec-
tion in an immunocompromised host, seeking to mimic
the clinical scenario of abdominal sepsis with superim-
posed VRE peritonitis. For this, mice were subjected to




Specific pathogen-free 10-week-old female C57BL/6
mice were purchased from Harlan Sprague-Dawley
(Horst, The Netherlands). The Animal Care and Use
Committee of the University of Amsterdam approved all
experiments.
Cecal ligation and puncture
CLP was performed as previously described [19]. Mice
were given buprenorphine (Temgesic, Schering-
Plough, Amstelveen, The Netherlands) 0.075 mg/kg
subcutaneously 30 min preoperatively, and were anes-
thetized via inhalation of a mixture of O2 (1–2 l/min)
and isoflurane 2.0–2.5% (Burtons, Kent, UK). During
surgery mice were kept on a heating pad at 37C
(Animed, Barneveld, The Netherlands). A 1-cm midline
incision was made on the abdomen, and the cecum
was exposed. The distal 1 cm of the cecum was ligated
with a 4–0 Vicryl suture (Ethicon, Johnson&Johnson,
St-Stevens-Woluwe, Belgium) and punctured through-
and-through with a 26-gauge needle (BD, Drogheda,
Ireland). A small amount of stool was extruded to
ensure wound patency. The cecum was replaced and the
abdomen was closed using Sofsilk 6–0 (Ethicon). This
model results in a marked septic response and death in
0–10% of animals. Sham animals underwent an identi-
cal laparotomy; the cecum was exposed but not ligated
or punctured and replaced. All mice were administered
1 ml of sterile saline subcutaneously for fluid resusci-
tation post-operatively and 500 ll saline twice daily
thereafter, containing 0.05 mg/kg buprenorphine. Nine
and eight mice were included in the CLP or sham group
per time point, respectively.
Induction of VRE peritonitis
Forty-eight hours after surgery, VRE peritonitis was
induced as previously described [18]. Mice were injected
intraperitoneally with approximately 108 colony-forming
units (CFU) of VRE in 200 ll sterile saline. Mice were
killed 2 h, 1, 2 and 5 days thereafter.
Bacterial strain
VRE strain, E155, was used in all experiments. This
clinical isolate from the Cook County Hospital, Chicago,
IL, belongs to a genetic subpopulation of hospital-asso-
ciated E. faecium that is responsible for the worldwide
emergence of nosocomial multiresistant E. faecium,
characterized by high-level quinolon and ampicillin
resistance, a pathogenicity island, containing the variant
esp gene, and the presence of five cell surface protein
genes [20, 21].
Collection of samples
Mice were anesthetized by inhalation of isoflurane
(Abbot, Laboratories Ltd., Kent, UK)/02 (2%/2 l), a per-
itoneal lavage was performed with 5 ml sterile phosphate-
buffered-saline using a 18-gauge needle; peritoneal
lavage fluid (PLF) was collected in sterile polypropylene
tubes (BD, Breda, The Netherlands). Blood was drawn by
cardiac puncture, transferred to heparin-gel vacutainer
tubes and placed on ice. Liver and lungs were harvested.
PLF supernatants and plasma were stored at -20C until
further examination.
Determination of bacterial outgrowth
The number of VRE CFU was determined in PLF, blood,
liver and lung homogenates. The organs were homogenized
in four volumes of saline and serial tenfold dilutions were
made of the homogenates, PLF and blood, then 50 ll of
each dilution was plated. Samples were plated on Slanetz-
Bertley (SB) agar plates (Oxoid, Badhoevedorp, The
Netherlands), supplemented with vancomycin (6 lg/ml),
to determine the amount of VRE. No bacterial growth was
observed when fecal pellets of naive mice were plated on
these plates. Additionally, samples were plated onto BA,
MacConkey (McC) (Difco, Detroit, MI) and colistin nali-
dixic acid (CNA) agar (BD, Breda, The Netherlands) for
quantification of total aerobic, gram-negative and gram-
positive bacteria, respectively. The plates were incubated at
37C under 5% CO2, and CFU were counted after 20 (BA
and McC) or 44 (SB and CNA) hours.
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Cell counts and differentials
Total cell numbers were counted from each PLF sample
using a hemocytometer (Beckman coulter, Fullerton, CA,
USA). Differential cell counts were performed on cyto-
spin preparations, stained with Giemsa (Diff-Quick; Dade
Behring), by an investigator blinded for experimental
groups.
Assays
Macrophage inflammatory protein (MIP)-2, cytokine-
induced neutrophil chemoattractant (KC) and LPS-
induced C-X-C chemokine (LIX) were measured in PLF
by ELISA’s (R&D Systems, Minneapolis, MN)
according to the manufacturers’ instructions. Tumor
necrosis factor (TNF)-a, interleukin (IL)-6, IL-10, IL-
12p70, interferon (IFN)-c and monocyte chemoattractant
protein (MCP)-1 were measured in PLF and plasma by
using a commercially available cytometric bead array
(CBA) multiplex assay (BD Biosciences, San Jose, CA,
USA) in accordance with the manufacturer’s recom-
mendations. Aspartate aminotransferase (ASAT) and
creatinine were determined in plasma with commer-
cially available kits (Sigma-Aldrich, St. Louis, MO,
USA), using a Hittachi analyzer (Boehringer Mannheim,
Mannheim, Germany).
Organ pathology
Livers and lungs were fixed in formaldehyde and
embedded in paraffin for histological examination. Sec-
tions of 4 lm were stained with hematoxylin-eosin, and
analyzed by a pathologist blinded for groups. To score
liver injury, interstitial inflammation, thrombi, hepato-
cellular necrosis and portal inflammation were analyzed.
Lungs were scored for interstitial inflammation, edema,
pleuritis and thrombi [22].
Statistical analysis
Data are expressed as mean ± SEM. Serial data were
analyzed by two-way analysis of variance (ANOVA)
followed by a post hoc Bonferroni test. Two group
comparisons were done by Mann-Whitney U test.
GraphPad Prism version 4 (GraphPad Software, San
Diego, CA, USA) was used. A P-value \0.05 was con-
sidered statistically significant.
Results
CLP strongly impairs clearance of VRE
To obtain insight into the impact of abdominal sepsis on
host defense against VRE, mice were intraperitoneally
Fig. 1 CLP causes a severe
impairment in peritoneal and
systemic clearance of E.
faecium. Respectively, 8 and 9
mice per time point underwent
sham surgery (triangles) or CLP
(circles) and received an
intraperitoneal injection with
108 CFU E. faecium 48 h after
the procedure. Two hours, 1, 2
and 5 days after E. faecium
infection mice were killed.
Mean (±SEM) E. faecium CFU
in a peritoneal lavage fluid
(PLF), b blood, c liver, and d
lung are shown. During the
5 days of the experiment 6% of
the mice that underwent CLP
and had a subsequent VRE
infection died. P values in
figure represent the overall
difference between groups;
asterisks indicate differences
between groups at one time
point. *P \ 0.05, **P \ 0.01,
***P \ 0.001 compared to
sham operated mice
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injected with a non-lethal amount of VRE (108 CFU) or
saline at 48 h after CLP or sham surgery. CLP was
associated with a strongly impaired clearance of VRE in
all organs examined (Fig. 1). Sham mice showed a rapid
decline in enterococcal loads from the peritoneal cavity;
2 days after infection VRE could not be recovered any-
more from blood, liver or lungs and only 2/8 sham mice
still had VRE in their peritoneal cavity. In contrast, in
CLP mice enterococcal loads remained high in all body
compartments examined for up to 5 days; 2 days after
infection VRE loads were [1,000-fold higher in PLF,
blood, liver and lungs of mice that had undergone CLP.
CLP results in a diminished neutrophil influx
in response to VRE peritonitis
Peritoneal leukocyte counts and differentials did not differ
significantly between CLP and sham mice 48 h after the
procedure (directly before infection with VRE) (Fig. 2a,
b). Sham mice demonstrated a strong and rapid increase
in neutrophil counts in PLF peaking 2 h after infection
with VRE. In contrast, CLP mice did not respond with an
influx of neutrophils to the primary site of VRE infection,
and neutrophil counts remained undistinguishable from
CLP mice not infected with VRE (Fig. 2a). Peritoneal
neutrophil numbers increased in all CLP mice later on
irrespective of VRE infection, as a consequence of the
CLP induced polymicrobial peritonitis [23]. After infec-
tion with VRE, both sham and CLP mice had an initial
drop in macrophage numbers, followed by an increase
after 24 h (Fig. 2b). CLP mice not infected with VRE had
no significant change in macrophage numbers during this
period. Sham mice injected with saline did not show any
important changes in peritoneal cell numbers and differ-
entials. CLP mice displayed highest numbers of
neutrophils and macrophages at 48 h after VRE or saline
injection (not shown). At 5 days peritoneal cells from all
mice were back to naı¨ve levels (not shown).
The murine CXC chemokines KC, MIP-2 and LIX are
known neutrophil attracting and activating mediators.
Sham mice responded with an increase in KC and LIX
levels 2 h after VRE infection (Fig. 2c, d), whereas CLP
mice subsequently infected did not. MIP-2 levels were
low in all mice (not shown). Sham mice not infected with
VRE showed low or undetectable chemokine levels
throughout the entire experiment (not shown).
CLP causes an impaired peritoneal cytokine response
to VRE peritonitis
At 48 h after CLP, directly before the administration of
VRE, plasma and PLF concentrations of TNF-a, IL-6,
Fig. 2 CLP results in reduced peritoneal neutrophil influx and
CXC chemokine release. Mean (±SEM) of peritoneal neutrophil
(a) and macrophage (b) counts and KC (c) and LIX (d)
concentrations. Mice were challenged with 108 CFU E. faecium
(closed symbols) or saline (open symbols) 48 h after CLP (circles),
or sham surgery (triangles). Data are shown for 0, 2 and 24 h after
E. faecium or saline injection. N = 8–9 mice per group at each time
point. P values in figure represent the overall difference between
groups; asterisks indicate differences between groups at one time
point. **P \ 0.01, ***P \ 0.001 compared to sham operated and
E. faecium infected mice
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IL-10 and MCP-1 were similar to those measured 48 h
after sham surgery, except for peritoneal IL-10 levels,
which were higher after CLP (Fig. 3). The levels of these
mediators remained low throughout the following 5 days
in CLP mice not infected with VRE. Peritoneal IL-10
levels decreased from 24 h after VRE infection onward
(not shown). Sham mice displayed an increase in perito-
neal and plasma concentrations of TNF-a, IL-6, IL-10 and
MCP-1 2 h after infection with VRE; the levels of these
mediators rapidly decreased thereafter, returning to
baseline levels at 24 h after infection, with the exception
of peritoneal IL-10. At 2 and 5 days after infection, the
local and systemic concentrations of all mediators mea-
sured were either very low or undetectable (not shown).
Strikingly, in CLP mice peritoneal cytokine levels did not
increase after induction of VRE peritonitis. Interestingly,
CLP mice demonstrated a comparable increase in plasma
TNF-a and IL-6 levels relative to sham mice after
infection with VRE. Sham mice not infected with VRE
showed low or undetectable cytokine levels throughout
Fig. 3 CLP causes a reduced
peritoneal, but not plasma
cytokine response to E. faecium
infection. Mean (±SEM) of
peritoneal (a–d) and plasma
(e–h) cytokine levels. Mice
received 108 CFU E. faecium
(closed circles) or saline (open
circles) intraperitoneally 48 h
after CLP, or E. faecium after
sham surgery (triangles). TNF-
a, IL-6, IL-10 and MCP-1 levels
are shown for T = 0 (directly
before E. faecium or saline
injection) and 2 and 24 h
thereafter. N = 8–9 per group
at each time point. P values in
figure represent the overall
difference between groups;
asterisks indicate differences
between groups at one time
point. **P \ 0.01,
***P \ 0.001 compared to
sham operated and E. faecium
infected mice
928
the experiment; IFN-c and IL-12p70 levels were low or
undetectable in any of the mice (not shown).
VRE peritonitis does not impact on host defense
against CLP-induced sepsis
Superinfection with VRE did not result in increased CLP-
induced lethality: during the 5-day observation period 6%
of CLP mice with subsequent VRE infection died,
whereas 8% of CLP mice with subsequent saline injection
died. None of the sham mice died. Furthermore, no dif-
ferences in weight loss were seen between CLP mice with
or without VRE infection (not shown). CLP caused for-
mation of an intra-abdominal abscess surrounding the
ligated and perforated cecum, covered by small-bowel
loops. No difference in the aspect of the abscess was seen
after VRE infection compared to saline injection. No
other abscesses were found in the abdominal cavity or
organs up to 7 days after CLP. In addition, VRE infection
did not influence the gram-negative or gram-positive
bacterial loads in PLF, blood, liver or lungs after CLP
(shown for total aerobic bacterial loads in fig. 4). Only
mild inflammatory changes were seen in liver and lungs
upon histopathological examination that did not differ
between CLP mice with or without VRE infection (not
shown). Nonetheless, CLP did induce hepatocellular
injury and a reduced kidney function, as reflected by
elevated plasma concentrations of ASAT and creatinine,
respectively. However, ASAT and creatinine levels were
comparable between CLP mice with or without VRE
infection (Fig. 5). No pathology or altered ASAT or
creatinine levels were seen in sham mice (not shown).
Discussion
In this study, we demonstrate that polymicrobial sepsis
induced by CLP results in a strongly impaired peritoneal
and systemic clearance of VRE, accompanied by a pro-
foundly reduced early inflammatory response at the
primary site of VRE infection. Although CLP mice
infected with VRE had high enterococcal loads in mul-
tiple body sites for days, these animals did not show
increased organ damage when compared to CLP mice not
infected with VRE, as determined by histopathology of
lung and liver tissue and laboratory markers for liver and
kidney injury. These data suggest that infection and dis-
semination of VRE is greatly facilitated by sublethal
polymicrobial sepsis, but that—at least in this model—
VRE does not contribute to sepsis induced pathology to a
significant extent.
Infections with E. faecium are a major problem in
patients on intensive care units, and are associated with
increased morbidity and mortality [24–26]. These infec-
tions are of special concern as they are increasingly
difficult to treat due to the escalating antimicrobial
resistance expressed by E. faecium [27, 28]. The afore-
mentioned patient groups frequently suffer a period of
Fig. 4 Enterococcus faecium
infection does not influence
total aerobic bacterial loads
after CLP. Nine mice per time
point underwent CLP and
received 108 CFU E. faecium
(closed circles) or saline (open
circles) intraperitoneally 48 h
thereafter. Two hours, 1, 2 and
5 days after the second
challenge mice were killed.
Mean (±SEM) CFU of total
aerobic bacteria in a peritoneal
lavage fluid (PLF), b blood, c
liver, and d lung are shown.
During the 5 days of the
experiment 6% of the mice with
subsequent VRE infection died,
whereas 8% of the mice with
subsequent saline injection
died. No differences in aerobic
outgrowth were seen between
groups
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sepsis during their hospital stay. Sepsis has been associ-
ated with a vigorous proinflammatory response, which
contributes to the multisystem organ failure and mortality
[8, 9]. Additionally, septic insults initiate concurrent or
sequential anti-inflammatory cascades, which are impor-
tant to avoid detrimental inflammatory responses and
achieve immunological homeostasis. The anti-inflamma-
tory response has been implicated in the inability of
critically ill patients to eradicate the primary infection
responsible for sepsis and their propensity to acquire
secondary nosocomial infections [6–11].
CLP is considered a clinically relevant model for sepsis
since it mimics a common clinical scenario and is associ-
ated with an early hyper-inflammatory reaction followed
by a subsequent hypo-inflammatory phase [12, 29, 30].
Several studies have documented a reduced capacity to
release cytokines after CLP and a subsequent challenge
with bacterial antigens [23, 30, 31]. This sepsis-induced
immune hyporesponsiveness was shown to impair host
defense mechanisms in the lungs against Pseudomonas
aeruginosa and Streptococcus pneumoniae [13–15]. We
here used the CLP model of sepsis to study the course of
VRE peritonitis in a host with severe co-morbid disease.
Our main finding was that CLP renders the host less
capable of adequately responding to VRE, as reflected by a
diminished capacity to recruit neutrophils to the site of the
infection and to locally release chemokines and cytokines,
which resulted in a strongly reduced enterococcal clear-
ance from the peritoneal cavity and subsequent
dissemination. We measured increased peritoneal IL-10
levels 48 h after CLP, directly before VRE infection.
Considering that IL-10 is an anti-inflammatory cytokine
capable of inhibiting the production of proinflammatory
mediators [32, 33], this in part may explain the reduced
release of cytokines and chemokines into the peritoneal
cavity of CLP mice infected with VRE. Other factors
implicated in CLP induced immune suppression include
enhanced apoptosis of immune cells and increased
expression of inhibitors of Toll-like receptors [8, 9, 30, 34].
Sham operated control mice demonstrated an early
inflammatory response and a rapid clearance of VRE
similar to what we reported earlier in previously healthy
mice that had not been subjected to abdominal surgery
[18]. Hence, abdominal surgery per se does not appear to
have a major impact on host defense against VRE, at least
in this model.
Experimental studies have suggested that E. faecalis
can influence abscess formation [35]. In our study we
were unable to demonstrate that prolonged infection with
VRE influences abscess formation, morbidity, mortality
or organ damage in mice subjected to CLP. In addition,
VRE infection did not impact on bacterial burdens asso-
ciated with CLP. As such, our data argue against a causal
role for VRE in adverse clinical outcomes in patients
infected with this bacterium. We have to mention, how-
ever, that the mice used were healthy before going into
surgery and 10 weeks of age resembling a situation of
mid- to late-adolescence in humans. Additionally, the
intensity of polymicrobial sepsis in this CLP model was
relatively mild. It would be of interest to examine the
impact of VRE infections in other models with diverse
underlying illnesses, e.g., by using older male/female
mice, being in an immunocompromised state before per-
forming surgery.
However, our results clearly show that the host suf-
fering from sublethal polymicrobial sepsis induced by
CLP is severely impaired in clearing abdominal and
systemic VRE infection, most likely due to an incapacity
Fig. 5 Enterococcus faecium infection does not impact on CLP-
induced hepatocellular injury or renal insufficiency. Nine mice per
time point underwent CLP and received 108 CFU E. faecium
(closed circles) or saline (open circles) intraperitoneally 48 h
thereafter. Mice were killed directly before E. faecium infection
(gray bar) and 1, 2 and 5 days later. a Plasma concentrations of
ASAT and b creatinine. During the 5 days of the experiment 6% of
the mice with subsequent VRE infection died, whereas 8% of the
mice with subsequent saline injection died. Data are means ± SEM.
Dotted horizontal lines represent mean values of healthy mice
(N = 8). All values measured after CLP were higher than healthy
control values; differences between CLP mice with and without E.
faecium infection were not significant
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to respond to this bacterium at the primary site of
infection.
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